Related Experiment Videos
Cell-mediated immune response to human T-lymphotropic virus type I
Angelina J Mosley1, Becca Asquith, Charles R M Bangham
1Department of Immunology, Imperial College London, London, United Kingdom.
Viral Immunology
|July 23, 2005
Summary
Human T-lymphotropic virus type I (HTLV-I) infection involves a complex immune response. This review explores the roles of CD4(+) and CD8(+) T cells, and innate immunity in HTLV-I persistence and associated diseases like HAM/TSP.
Area of Science:
- Immunology
- Virology
- Neuroscience
Background:
- Human T-lymphotropic virus type I (HTLV-I) establishes persistent infections globally.
- The virus chronically activates cell-mediated immunity, but disease outcomes vary significantly among infected individuals.
- Most HTLV-I carriers remain asymptomatic, while a subset develops the inflammatory neurological condition HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Purpose of the Study:
- To review the current understanding of the cell-mediated immune response to HTLV-I infection.
- To explore the specific roles of CD4(+) and CD8(+) T cells in HTLV-I pathogenesis and disease progression.
- To consider the potential involvement of innate immune effectors in HTLV-I infection.
Main Methods:
- Review of recent immunological studies on HTLV-I.
- Analysis of data on HTLV-I-specific CD4(+) T cell responses.
- Examination of studies on CD8(+) T cell function and gene expression profiles.
Main Results:
- The CD4(+) T cell response is implicated in HAM/TSP pathogenesis.
- The precise role of CD8(+) T cells in controlling HTLV-I or contributing to HAM/TSP remains debated.
- Emerging evidence suggests a potential role for innate immune cells in HTLV-I infection.
Conclusions:
- The immune response critically influences HTLV-I infection outcomes.
- Further research into T cell dynamics and innate immunity is crucial for understanding HAM/TSP.
- Elucidating these immune mechanisms may lead to novel therapeutic strategies for HTLV-I-related diseases.